Daniele Pastori

Pubblicazioni

Titolo Pubblicato in Anno
Reduced lysosomal acid lipase activity in adult patients with non-alcoholic fatty liver disease EBIOMEDICINE 2015
Relationship between Mediterranean diet and time in therapeutic range in atrial fibrillation patients taking Vitamin K antagonists EUROPACE 2015
Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2015
Similar reduction of cholesterol-adjusted Vitamin E serum levels in simple steatosis and non-alcoholic steatohepatitis CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY 2015
Reply to "The relation between flow mediated dilation and atrial fibrillation" by S. Balta: Refers to Sevket Balta, MD et al. INTERNATIONAL JOURNAL OF CARDIOLOGY 2015
Lights and shadows in the management of old and new oral anticoagulants in the real world of atrial fibrillation by italian internists. a survey from the atrial fibrillation registry for ankle-brachial index prevalence assessment-collaborative italian study EUROPEAN JOURNAL OF INTERNAL MEDICINE 2015
Extra virgin olive oil use is associated with improved post-prandial blood glucose and LDL cholesterol in healthy subjects NUTRITION & DIABETES 2015
Nutritional and therapeutic approaches to modulate NADPH oxidase-derived ROS signaling in platelets CURRENT PHARMACEUTICAL DESIGN 2015
Inadequate anticoagulation by vitamin K antagonists is associated with major adverse cardiovascular events in patients with atrial fibrillation INTERNATIONAL JOURNAL OF CARDIOLOGY 2015
Oxidative stress: new insights on the association of nonalcoholic fatty liver disease and atherosclerosis WORLD JOURNAL OF HEPATOLOGY 2015
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study BMJ OPEN 2015

ERC

  • LS4
  • LS4_10
  • LS7
  • LS7_10

Keywords

cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma